A comparison of parenteral phenobarbital vs. parenteral phenytoin as second-line management for pediatric convulsive status epilepticus in a resource-limited setting
<p><strong>Introduction:</strong> Pediatric convulsive status epilepticus (CSE) which is refractory to first-line benzodiazepines is a significant clinical challenge, especially within resource-limited countries. Parenteral phenobarbital is widely used in Africa as second-line agen...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Frontiers Media
2019
|